Lv7
4990 积分 2022-01-22 加入
Efficacy and safety of hepatic arterial infusion chemotherapy combined with donafenib in the treatment of unresectable hepatocellular carcinoma
4小时前
待确认
Association between vitamin D supplementation and mortality: systematic review and meta-analysis
6个月前
已完结
Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma
7个月前
已完结
Cancer incidence and mortality in China, 2022
7个月前
已完结
Sintilimab plus bevacizumab combined with radiotherapy as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A multicenter, single-arm, phase 2 study
8个月前
已完结
Induction therapy with hepatic arterial infusion chemotherapy enhances the efficacy of lenvatinib and pd1 inhibitors in treating hepatocellular carcinoma patients with portal vein tumor thrombosis
8个月前
已完结
Efficacy and Safety of Stereotactic Body Radiotherapy Combined with Camrelizumab and Apatinib in Patients with Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
8个月前
已完结
Radiotherapy prior to or after transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus: a randomized controlled trial
8个月前
已完结
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
9个月前
已完结
Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
9个月前
已完结
皖公网安备34019202002308
